Norges Bank Watch 2015: An Independent Evaluation of Monetary Policy in Norway by Aamdal, Kyrre, Lommerud, Kjell Erik

Request full text

Nibor - intet mysterium by Aamdal, Kyrre

Request full text

Norges Bank Watch 2014: An Independent Evaluation of Monetary Policy in Norway by Mork, Knut Anton, Freixas, Xavier, Aamdal, Kyrre

Request full text

Kommunal ressursbruk og tjenesteyting: Makromodellen MAKKO by Aamdal, Kyrre

Request full text

Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma by Nyakas, M., Aamdal, E., Jacobsen, K. D., Guren, T. K., Aamdal, S., Hagene, K. T., Brunsvig, P., Yndestad, A., Halvorsen, B., Tasken, K. A., Aukrust, P., Mælandsmo, G. M., Ueland, T.

Get full text

Combining a Universal Telomerase Based Cancer Vaccine With Ipilimumab in Patients With Metastatic Melanoma - Five-Year Follow Up of a Phase I/IIa Trial by Aamdal, Elin, Inderberg, Else Marit, Ellingsen, Espen Basmo, Rasch, Wenche, Brunsvig, Paal Fredrik, Aamdal, Steinar, Heintz, Karen-Marie, Vodák, Daniel, Nakken, Sigve, Hovig, Eivind, Nyakas, Marta, Guren, Tormod Kyrre, Gaudernack, Gustav

Get full text

Plasma protein dynamics during ipilimumab treatment in metastatic melanoma: associations with tumor response, adverse events and survival by Lereim, Ragnhild Reehorst, Dunn, Claire, Aamdal, Elin, Chauhan, Sudhir Kumar, Straume, Oddbjørn, Guren, Tormod Kyrre, Kyte, Jon Amund

Get full text

Long-Term Outcomes of a Phase I Study With UV1, a Second Generation Telomerase Based Vaccine, in Patients With Advanced Non-Small Cell Lung Cancer by Brunsvig, Paal F, Guren, Tormod Kyrre, Nyakas, Marta, Steinfeldt-Reisse, Claudius H, Rasch, Wenche, Kyte, Jon Amund, Juul, Hedvig Vidarsdotter, Aamdal, Steinar, Gaudernack, Gustav, Inderberg, Else Marit

Get full text

Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials by Ellingsen, Espen Basmo, Aamdal, Elin, Guren, Tormod, Lilleby, Wolfgang, Brunsvig, Paal F, Mangsbo, Sara M, Aamdal, Steinar, Hovig, Eivind, Mensali, Nadia, Gaudernack, Gustav, Inderberg, Else Marit

Get full text

Ipilimumab in a real-world population: A prospective Phase IV trial with long-term follow-up by Aamdal, Elin, Jacobsen, Kari Dolven, Straume, Oddbjørn, Kersten, Christian, Herlofsen, Oluf, Karlsen, Jarle, Hussain, Israr, Amundsen, Anita, Dalhaug, Astrid, Nyakas, Marta Sølvi, Schuster, Cornelia, Hagene, Kirsten Thorin, Holmsen, Kjersti, Russnes, Hege Elisabeth Giercksky, Skovlund, Eva, Kaasa, Stein, Aamdal, Steinar, Kyte, Jon A, Guren, Tormod Kyrre

Get full text

Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma by Nyakas, Marta Sølvi, Aamdal, Elin, Jacobsen, Kari Dolven, Guren, Tormod Kyrre, Aamdal, Steinar, Hagene, Kirsten Thorin, Brunsvig, Paal Fr, Yndestad, Arne, Halvorsen, Bente, Tasken, Kristin Austlid, Aukrust, Pål, Mælandsmo, Gunhild Mari, Ueland, Thor

Get full text

Abstract B141: Combining the telomerase peptide cancer vaccine UV1 with CTLA-4 blockade in patients with metastatic malignant melanoma: Proof of principle and early clinical report... by Aamdal, Elin, Guren, Tormod Kyrre, Suso, Else Marit Inderberg, Kvalheim, Gunnar, Kyte, Jon Amund, Arnesen, Øyvind Kongstun, Aamdal, Steinar, Gaudernack, Gustav

Get full text

Health-related quality of life in patients with advanced melanoma treated with ipilimumab: prognostic implications and changes during treatment by Aamdal, Elin, Skovlund, Eva, Jacobsen, Kari Dolven, Straume, Oddbjørn, Kersten, Christian, Herlofsen, Oluf, Karlsen, Jarle, Hussain, Israr, Amundsen, Anita, Dalhaug, Astrid, Nyakas, Marta Sølvi, Hagene, Kirsten Thorin, Holmsen, Kjersti, Aamdal, Steinar, Kaasa, Stein, Guren, Tormod Kyrre, Kyte, Jon A

Request full text

Health-related quality of life in patients with advanced melanoma treated with ipilimumab: prognostic implications and changes during treatment by Aamdal, Elin, Skovlund, Eva, Jacobsen, Kari Dolven, Straume, Oddbjørn, Kersten, Christian, Herlofsen, Oluf, Karlsen, Jarle, Hussain, Israr, Amundsen, Anita, Dalhaug, Astrid, Nyakas, Marta Sølvi, Hagene, Kirsten Thorin, Holmsen, Kjersti, Aamdal, Steinar, Kaasa, Stein, Guren, Tormod Kyrre, Kyte, Jon A

Request full text

Ipilimumab in a real-world population: A prospective Phase IV trial with long-term follow-up by Aamdal, Elin, Jacobsen, Kari Dolven, Straume, Oddbjørn, Kersten, Christian, Herlofsen, Oluf, Karlsen, Jarle, Hussain, Israr, Amundsen, Anita, Dalhaug, Astrid, Nyakas, Marta Sølvi, Schuster, Cornelia, Hagene, Kirsten Thorin, Holmsen, Kjersti, Russnes, Hege Elisabeth Giercksky, Skovlund, Eva, Kaasa, Stein, Aamdal, Steinar, Kyte, Jon A, Guren, Tormod Kyrre

Request full text

Ipilimumab in a real-world population: A prospective Phase IV trial with long-term follow-up by Aamdal, Elin, Jacobsen, Kari Dolven, Straume, Oddbjørn, Kersten, Christian, Herlofsen, Oluf, Karlsen, Jarle, Hussain, Israr, Amundsen, Anita, Dalhaug, Astrid, Nyakas, Marta Sølvi, Schuster, Cornelia, Hagene, Kirsten Thorin, Holmsen, Kjersti, Russnes, Hege Elisabeth Giercksky, Skovlund, Eva, Kaasa, Stein, Aamdal, Steinar, Kyte, Jon A, Guren, Tormod Kyrre

Request full text